Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,733 | 234 | 53.8% |
| Gift | $4,006 | 2 | 45.6% |
| Entertainment | $34.39 | 3 | 0.4% |
| Education | $21.09 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tosoh Bioscience, Inc. | $4,006 | 2 | $0 (2019) |
| ABBVIE INC. | $1,624 | 89 | $0 (2024) |
| Boston Scientific Corporation | $434.02 | 10 | $0 (2023) |
| PFIZER INC. | $409.27 | 13 | $0 (2020) |
| Merck Sharp & Dohme LLC | $229.02 | 7 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $218.60 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $196.72 | 13 | $0 (2023) |
| Romark Laboratories, LC | $187.84 | 19 | $0 (2019) |
| Braintree Laboratories, Inc. | $169.15 | 10 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $166.65 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $558.53 | 24 | ABBVIE INC. ($284.44) |
| 2023 | $712.71 | 33 | AbbVie Inc. ($336.89) |
| 2022 | $663.20 | 29 | ABBVIE INC. ($378.89) |
| 2021 | $470.88 | 21 | AbbVie Inc. ($139.21) |
| 2020 | $96.65 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($18.92) |
| 2019 | $4,918 | 43 | Tosoh Bioscience, Inc. ($4,006) |
| 2018 | $799.16 | 45 | AbbVie, Inc. ($169.98) |
| 2017 | $575.12 | 40 | AbbVie, Inc. ($196.64) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: VIROLOGY | ||||||
| 09/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: GI | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: VIROLOGY | ||||||
| 08/01/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Immunology | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/07/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $88.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Gastroenterology | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: GI | ||||||
| 02/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,061 | 3,463 | $499,363 | $119,156 |
| 2022 | 21 | 1,005 | 1,260 | $449,083 | $113,271 |
| 2021 | 20 | 911 | 2,314 | $408,500 | $107,867 |
| 2020 | 17 | 738 | 873 | $321,439 | $76,775 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 281 | $94,707 | $28,767 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 110 | 111 | $56,166 | $15,920 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 115 | 182 | $34,126 | $11,993 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $32,777 | $9,844 | 30.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 80 | $76,321 | $7,674 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 104 | $24,644 | $7,145 | 29.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 29 | $31,665 | $6,343 | 20.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $48,020 | $6,010 | 12.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 21 | 21 | $18,438 | $4,157 | 22.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 21 | $19,404 | $3,790 | 19.5% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 22 | 23 | $11,663 | $3,499 | 30.0% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2023 | 14 | 15 | $9,013 | $2,671 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $10,474 | $2,563 | 24.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $11,251 | $2,194 | 19.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 25 | 27 | $3,456 | $1,358 | 39.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 16 | $3,792 | $1,236 | 32.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $5,094 | $1,147 | 22.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 12 | 13 | $3,751 | $902.81 | 24.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 25 | $1,500 | $625.75 | 41.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 51 | 62 | $678.00 | $485.52 | 71.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 27 | 30 | $780.00 | $300.15 | 38.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 31 | 37 | $703.00 | $273.96 | 39.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 22 | 2,200 | $940.00 | $258.72 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 287 | $96,245 | $29,966 | 31.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 99 | 101 | $51,106 | $16,864 | 33.0% |
About Dr. Khurram Ashraf, DO
Dr. Khurram Ashraf, DO is a Gastroenterology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811991508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khurram Ashraf, DO has received a total of $8,794 in payments from pharmaceutical and medical device companies, with $558.53 received in 2024. These payments were reported across 241 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,733).
As a Medicare-enrolled provider, Ashraf has provided services to 3,715 Medicare beneficiaries, totaling 7,910 services with total Medicare billing of $417,069. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Poughkeepsie, NY
- Active Since 06/09/2005
- Last Updated 04/23/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1811991508
Products in Payments
- 25-OH Vitamin D ST AIA-Pack (Medical Supply) $2,003
- TES, ST AIA-PACK (Medical Supply) $2,003
- RINVOQ (Biological) $471.11
- XELJANZ (Drug) $393.55
- Humira (Biological) $243.15
- MAVYRET (Drug) $230.19
- DIFICID (Drug) $210.74
- EXALT Model D (Device) $209.40
- OCALIVA (Drug) $198.96
- SKYRIZI (Biological) $195.35
- XIFAXAN (Drug) $180.35
- Entyvio (Biological) $152.90
- Linzess (Drug) $151.37
- Mavyret (Drug) $129.78
- Alinia Tablets 500mg 30 count bottle (Drug) $104.31
- EXALT (Device) $100.00
- HUMIRA (Biological) $92.64
- CLENPIQ (Drug) $90.49
- CREON (Drug) $88.04
- Alinia (Drug) $83.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Poughkeepsie
Anthony Starpoli, M.d, M.D
Gastroenterology — Payments: $47,720
Dr. Robert Dean, Md, MD
Gastroenterology — Payments: $37,658
Dr. Peter Varunok, Md, MD
Gastroenterology — Payments: $35,234
Ravi Hotchandani, Md, MD
Gastroenterology — Payments: $28,261
Dr. Salvatore Buffa, Md, MD
Gastroenterology — Payments: $13,778
Dr. Farah Toyserkani, Md, MD
Gastroenterology — Payments: $10,977